These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 2169955)
1. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density. Masuo Y; Montagne MN; Pélaprat D; Scherman D; Rostène W Brain Res; 1990 Jun; 520(1-2):6-13. PubMed ID: 2169955 [TBL] [Abstract][Full Text] [Related]
2. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density. Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504 [TBL] [Abstract][Full Text] [Related]
4. [3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum. Masuo Y; Pélaprat D; Scherman D; Rostène W Neurosci Lett; 1990 Jun; 114(1):45-50. PubMed ID: 1974339 [TBL] [Abstract][Full Text] [Related]
5. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems. Singh NA; Bush LG; Gibb JW; Hanson GR Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat. Ferraro L; O'Connor WT; Antonelli T; Fuxe K; Tanganelli S Eur J Neurosci; 1997 Sep; 9(9):1838-46. PubMed ID: 9383206 [TBL] [Abstract][Full Text] [Related]
7. Opposite effects of intranigral ibotenic acid and 6-hydroxydopamine on motor behavior and on striatal neuropeptide Y neurons. Nitsch C; Wolfrum G; Schaefer F; Scotti AL; Unger J Brain Res Bull; 1993; 30(1-2):21-32. PubMed ID: 8420631 [TBL] [Abstract][Full Text] [Related]
8. Autoradiographic localisation of D1 and D2 dopamine receptors in primordial striatal tissue grafts in rats. Mayer E; Heavens RP; Sirinathsinghji DJ Neurosci Lett; 1990 Feb; 109(3):271-6. PubMed ID: 2139499 [TBL] [Abstract][Full Text] [Related]
9. Changes in gamma-aminobutyric acid, mu-opioid and neurotensin receptors in the accumbens-pallidal projection after discrete quinolinic acid lesions in the nucleus accumbens. Churchill L; Dilts RP; Kalivas PW Brain Res; 1990 Mar; 511(1):41-54. PubMed ID: 2158856 [TBL] [Abstract][Full Text] [Related]
11. Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat. Ferraro L; O'Connor WT; Beggiato S; Tomasini MC; Fuxe K; Tanganelli S; Antonelli T Eur J Neurosci; 2012 Jan; 35(2):207-20. PubMed ID: 22211865 [TBL] [Abstract][Full Text] [Related]
12. The localization of receptor binding sites in the substantia nigra and striatum of the rat. Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532 [TBL] [Abstract][Full Text] [Related]
13. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy. Calderon SF; Sanberg PR; Norman AB Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764 [TBL] [Abstract][Full Text] [Related]
14. Ibotenic acid-induced lesions of striatal target and projection neurons: ultrastructural manifestations in dopaminergic and non-dopaminergic neurons and in glia. Smith DE; Saji M; Joh TH; Reis DJ; Pickel VM Histol Histopathol; 1987 Jul; 2(3):251-63. PubMed ID: 2908792 [TBL] [Abstract][Full Text] [Related]
15. Fetal striatal transplants restore electrophysiological sensitivity to dopamine in the lesioned striatum of rats with experimental Huntington's disease. Chen GJ; Jeng CH; Lin SZ; Tsai SH; Wang Y; Chiang YH J Biomed Sci; 2002; 9(4):303-10. PubMed ID: 12145527 [TBL] [Abstract][Full Text] [Related]
17. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related]
18. Neurotensin regulation of endogenous acetylcholine release from rat striatal slices is independent of dopaminergic tone. Lapchak PA; Araujo DM; Quirion R; Beaudet A J Neurochem; 1991 Feb; 56(2):651-7. PubMed ID: 1899109 [TBL] [Abstract][Full Text] [Related]
19. Effect of neurotensin and immunneutralization with anti-neurotensin-serum on dopaminergic-cholinergic interaction in the striatum. Töröcsik A; Rakovska A; Görcs T; Vizi ES Brain Res; 1993 May; 612(1-2):306-12. PubMed ID: 8101133 [TBL] [Abstract][Full Text] [Related]
20. Striatal lesions and transplants demonstrate that cholecystokinin receptors are localized on intrinsic striatal neurones: a quantitative autoradiographic study. Beresford IJ; Hall MD; Clark CR; Hill RG; Hughes J; Sirinathsinghji DJ Neuropeptides; 1987; 10(2):109-36. PubMed ID: 2960910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]